A new age of genetic screening is coming — and we don’t have any rules for it
By Dalton Conley,
The Washington Post
| 06. 14. 2021
New ‘polygenic’ screening techniques open a Pandora’s Box of ethical issues.
After the coronavirus baby bust is over and fertility clinics are booming again, increasing numbers of new parents will bring home a generation of infants prescreened to perform better at school or basketball, resist heart disease or be less likely to have schizophrenia.
It may not be common yet, but the ability to screen embryos for any number of traits is here now, and improving every day. And this brave new world of genetic prediction I’m describing is not just about selecting babies during in vitro fertilization. It could also involve life insurance companies swabbing your cheek before issuing you a policy, preschools and colleges scoring your DNA as part of their admissions process and dating sites asking for your genetic profile before offering you a match.
But with this new technology comes countless ethical questions. Is embryo selection a good thing or a bad thing — or both? How do we balance potential inequities created against potential lives saved or improved? Do we want to keep genetics from becoming destiny, and what does that even mean? We desperately need...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Tory Shepherd, The Guardian | 06.13.2025
IVF is “big business” and experts are concerned about conflicts of interest between profit-making and helping families have children.
Monash IVF’s second embryo bungle has sparked renewed scrutiny on the IVF industry as a whole amid calls for national regulation...